You May Be Eligible for Financial Compensation!
Limited Time to File Your Claim!
By clicking the “SEE IF I QUALIFY” button above, you agree that you will be contacted by telephone, email SMS/Text Message (Data Rates May Apply), even if you are on a federal or state Do Not Call registry, to confirm the accuracy of the information you submit and verify if you qualify.
What is Zantac (Ranitidine)?
Zantac, the most popular ranitidine brand, is used to help reduce stomach acid. The medication is commonly prescribed to treat ulcers, gastroesophageal reflux disease (GERD), chronic indigestion, and Zollinger-Ellison syndrome. It comes in over-the-counter and prescription strengths that may be taken by mouth or administered via injection into a muscle or vein.
The manufacturers of Zantac and generic ranitidine products have warned patients and healthcare providers about the following potential side effects but to this day, have never warned about any potential exposure to a carcinogen:
- Gastrointestinal side effects (constipation, diarrhea, nausea, abdominal pain)
- Drowsiness, dizziness
- Sleep problems
- Decreased sex drive
- Swollen or tender breasts (in men)
- At high doses, may affect liver function
WHAT IS NDMA?
N-Nitrosodimethylamine, or NDMA, is an environmental contaminant in our food and water. Many people consume small doses of NDMA when they eat vegetables, grilled meats, or dairy products, but mild exposure does not cause serious health concerns. Over time, however, NDMA can build up in the body and lead to cancer.
The FDA recommends NDMA consumption be limited to 0.096 micrograms per day and does not allow medications to contain more than 0.32 parts per million (ppm) of NDMA.
During laboratory testing, ranitidine samples contained up to 0.86 micrograms per tablet and up to 2.85 ppm. Zantac was contaminated with as many as 0.36 micrograms of NDMA and up to 2.38 ppm per dose.
Zantac Recalled Due to Potential Cancer Risk
The popular heartburn medication, Zantac, is under investigation by the U.S. Food and Drug Administration (FDA) and has been linked to cancer in several lawsuits.
In September of 2019, an independent pharmacy, Valisure, sent a citizen’s petition to the FDA, claiming Zantac and its generic versions were contaminated with a probable human carcinogen NDMA (a substance that could cause cancer).
On April 1, 2020, the FDA requested that all Ranitidine (Zantac) products be removed from the market.
We Can Help
Our network of attorneys have been helping individuals, like you, for years.
Do I Have A Case
You may be entitled to financial compensation if you or a loved one have been using over-the-counter Zantac.
Our team of experts has extensive experience fighting to hold manufacturers and distributers accountable.
Contact us right away to set up a free, confidential and no-obligation case review. We’re ready to fight for you.
27475 Ynez Rd #708, Temecula, CA 92591